Biomaterial-based platforms for in situ dendritic cell programming and their use in antitumor immunotherapy

Biomaterial-based platforms for in situ dendritic cell programming and their use in antitumor immunotherapy

Abstract Dendritic cells (DCs) are central players in the immune system, with an exquisite capacity to initiate and modulate immune responses. These functional characteristics have led to intense research on the development of DC-based immunotherapies, particularly for oncologic diseases. During rec...

Full description

Bibliographic Details
Main Authors: João Calmeiro, Mylène Carrascal, Célia Gomes, Amílcar Falcão, Maria Teresa Cruz, Bruno Miguel Neves
Format: Article
Language:English
Published: BMJ Publishing Group 2019-09-01
Series:Journal for ImmunoTherapy of Cancer
Subjects:
Biomaterial-based scaffolds
Dendritic cells
In situ mobilization
Antitumor immunotherapy
Online Access:http://link.springer.com/article/10.1186/s40425-019-0716-8

Internet

http://link.springer.com/article/10.1186/s40425-019-0716-8

Similar Items